Immunogenic compositions comprising HIV-1 acetylated Tat polypeptides
US7482016B2 · kind B2 · utility
13Cited by
3References
26Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 12, 2004 |
| Grant date | Jan 27, 2009 |
| Priority date | — |
| Expiry date | Oct 29, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16334
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions, including immunogenic compositions, comprising acetylated Tat protein of an immunodeficiency virus. The present invention further provides antibodies that specifically bind an acetylated Tat polypeptide. The present invention further provides methods of inducing an immune response to an immunodeficiency virus Tat protein in an individual. The present invention further provides methods of inhibiting transcriptional activation of an immunodeficiency virus in a cell of an individual.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.